共 186 条
[1]
Masters CL(2015)Alzheimer’s disease Nat Rev Dis Primers 1 505-517
[2]
Bateman R(2016)Alzheimer’s disease Lancet. 388 595-608
[3]
Blennow K(2016)The amyloid hypothesis of Alzheimer’s disease at 25 years EMBO Mol Med 8 319-329
[4]
Rowe CC(2014)Targeting the beta secretase BACE1 for Alzheimer’s disease therapy Lancet Neurol 13 1430-1440
[5]
Sperling RA(2012)Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease Arch Neurol 69 341-350
[6]
Cummings JL(2013)A phase 3 trial of semagacestat for treatment of Alzheimer’s disease N Engl J Med 369 311-321
[7]
Scheltens P(2014)Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease N Engl J Med 370 322-333
[8]
Blennow K(2014)Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease N Engl J Med 370 50-56
[9]
Breteler MM(2016)The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Nature 537 4-28
[10]
de Strooper B(2014)Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects J Neurochem 130 158-169